<DOC>
	<DOCNO>NCT02569892</DOCNO>
	<brief_summary>This randomize control study non-damaging photothermal macular grid laser versus sham laser therapy patient dry age-related macular degeneration ( AMD ) large high-risk drusen . The goal study determine treatment reduce macular drusen volume also whether might improve visual acuity reduce risk conversion advance age-related macular degeneration define development choroidal neovascularization geographic atrophy .</brief_summary>
	<brief_title>Non-Damaging Photothermal Therapy Non-exudative Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<mesh_term>Retinal Drusen</mesh_term>
	<criteria>Inclusion Criteria 1 . Older 60 year age . 2 . Male female patient nonexudative AMD drusen volume least 0.03mm3 central 3mm circle 3 . Adequate pupil dilatation clear medium perform colour , redfree image fundus fluorescein angiography , fundus autofluorescence image OCT. 4 . Able give inform consent . 1 . Presence sign advance AMD , CNV , haemorrhages macular atrophy base OCT fundus autofluorescence photography ( FAF ) . 2 . Previous macular laser treatment . 3 . Any previous ocular condition may associate risk develop macular oedema . 4 . Vitreomacular traction determine clinically /or OCT , opinion investigator , contribute macular oedema ( associate cause detachment fovea ) . 5 . Presence macular disease epiretinal membrane , macular telangiectasia . 6 . Important known allergy sodium fluorescein dye use angiography . 7 . Ocular periocular infection . 8 . Planned intraocular surgery within one year . 9 . Patient unavailable followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>